Trial Profile
Study of the clinical utility and safety in combination use of the GLI-1 analogue and Insulin degludec in type 2 diabetic patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Jul 2015
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 22 Jul 2015 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 31 Mar 2015 New trial record